Lilly bypasses Australian pharmacies with direct-to-consumer model
Eli Lilly is selling drugs directly to patients in Australia, cutting out traditional pharmacies.
· 1 min read · 1 source
According to STAT, Eli Lilly is bypassing Australian pharmacies with a direct-to-consumer model. The report gives no further details on which drugs are involved or how the model operates.
The move marks a notable shift in how the company reaches patients in Australia, though the implications for pharmacists and patients remain unclear based on the information available.